Deep Genomics

Deep Genomics develops a machine learning technology to understand how genetic variations lead to diseases. It develops an integrated computational system that could learn, predict and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The Company offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome.

Company Growth (employees)
Type
Private
HQ
Toronto, CA
Founded
2014
Size (employees)
20 (est)+6%
Deep Genomics was founded in 2014 and is headquartered in Toronto, CA

Deep Genomics Office Locations

Deep Genomics has an office in Toronto
Toronto, CA (HQ)
MaRS Centre, Heritage Building, Suite 320

Deep Genomics Financials and Metrics

Summary Metrics

Founding Date

2014

Total Funding

$3.7 m

Latest funding size

$3.7 m

Time since last funding

almost 2 years

Investors

Deep Genomics's latest funding round in November 2015 was reported to be $3.7 m. In total, Deep Genomics has raised $3.7 m

Traffic Overview of Deep Genomics

Deep Genomics Online and Social Media Presence

Deep Genomics News and Updates

Deep Genomics lands $13 mln in follow-on round led by Khosla

Deep Genomics, a Toronto genetic medicine startup, has raised $13 million in follow-on financing. Khosla Ventures led the round and was joined by True Ventures, which led the company’s $5 million seed financing in 2015. Spun out of the University of Toronto in 2014, Deep Genomics is building a biolo…

Deep Genomics Company Life and Culture

You may also be interested in